How COVID-19 is changing the production of cell therapies

Implementation of contingency plans allows for continued progress in therapy development

Managing donor collections during the COVID-19 pandemic

Why a diverse apheresis center network is critical to business continuity

Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)

Why established systems and relationships matter

How to overcome 3 common cell therapy supply chain disruptions

Design a tailored logistics plan to deliver

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

The challenge of multiple audits and redundant training

A case study from UCLA Health

Developing and managing a strong collection center network

On-demand webinar available

‘There is no room for error’ in cell and gene therapy logistics

Delivering life-saving therapies on time, every time

The crucial role in delivering effective cell and gene therapies

How standardization can overcome challenges in apheresis